Vaccinex, Inc. (VCNX)
USD 1.0
(66.67%)
USD 1.0
(66.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -19.74 Million USD | -16.12% |
| 2022 | -19.6 Million USD | 11.99% |
| 2021 | -21.4 Million USD | 20.59% |
| 2020 | -28.05 Million USD | 11.26% |
| 2019 | -31.61 Million USD | -17.55% |
| 2018 | -28.9 Million USD | -28.44% |
| 2017 | -17.19 Million USD | -4.25% |
| 2016 | -10.77 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -5.07 Million USD | -13.13% |
| 2024 Q2 | -5.69 Million USD | -45.91% |
| 2023 FY | - USD | -16.12% |
| 2023 Q1 | -4.93 Million USD | 2.03% |
| 2023 Q4 | -4.96 Million USD | 14.96% |
| 2023 Q2 | -7.03 Million USD | -42.57% |
| 2023 Q3 | -5.83 Million USD | 17.01% |
| 2022 Q3 | -4.69 Million USD | 11.96% |
| 2022 FY | - USD | 11.99% |
| 2022 Q1 | -4.55 Million USD | 1.15% |
| 2022 Q2 | -5.32 Million USD | -17.02% |
| 2022 Q4 | -5.03 Million USD | -7.29% |
| 2021 Q2 | -5.58 Million USD | 9.78% |
| 2021 Q1 | -6.18 Million USD | -2.5% |
| 2021 FY | - USD | 20.59% |
| 2021 Q4 | -4.6 Million USD | 8.37% |
| 2021 Q3 | -5.02 Million USD | 9.94% |
| 2020 Q2 | -6.41 Million USD | 9.47% |
| 2020 Q1 | -7.08 Million USD | -13.2% |
| 2020 Q4 | -6.03 Million USD | 29.25% |
| 2020 FY | - USD | 11.26% |
| 2020 Q3 | -8.53 Million USD | -33.03% |
| 2019 Q2 | -8.77 Million USD | 2.62% |
| 2019 FY | - USD | -17.55% |
| 2019 Q4 | -6.25 Million USD | 17.42% |
| 2019 Q3 | -7.57 Million USD | 13.6% |
| 2019 Q1 | -9 Million USD | -7.33% |
| 2018 Q4 | -8.39 Million USD | -32.51% |
| 2018 FY | - USD | -28.44% |
| 2018 Q3 | -6.33 Million USD | 2.58% |
| 2018 Q2 | -6.5 Million USD | -14.72% |
| 2018 Q1 | -5.66 Million USD | 8.0% |
| 2017 Q1 | -4.87 Million USD | 0.0% |
| 2017 Q2 | -4.62 Million USD | 5.21% |
| 2017 Q3 | -5.27 Million USD | -14.17% |
| 2017 Q4 | -6.16 Million USD | -16.71% |
| 2017 FY | - USD | -4.25% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| America Great Health | -447.29 Thousand USD | -4315.013% |
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 33.071% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 82.685% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -25.297% |
| Better Therapeutics, Inc. | -38.26 Million USD | 48.387% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 48.391% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -10.407% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 41.458% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 40.826% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 81.43% |
| Evolutionary Genomics, Inc. | -913.47 Thousand USD | -2061.859% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 39.203% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 57.706% |
| Innovation1 Biotech Inc. | -5.68 Million USD | -247.447% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -21.144% |
| Molecular Templates, Inc. | 1.43 Million USD | 1480.979% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -42.327% |
| NexImmune, Inc. | -28.16 Million USD | 29.891% |
| Orgenesis Inc. | -60.71 Million USD | 67.476% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 61.5% |
| Point of Care Nano-Technology, Inc. | -73.41 Thousand USD | -26798.769% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -22.314% |
| Scopus BioPharma Inc. | -11.71 Million USD | -68.597% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 96.342% |
| Statera Biopharma, Inc. | 38.93 Million USD | 150.72% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -186.868% |
| Trevena, Inc. | -35.28 Million USD | 44.038% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -35132.199% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -1786.191% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 57.859% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -171.898% |